Preclinical assessment of JNJ-26854165 (Serdemetan 1 Serdemetan is the proposed International Nonproprietary Name (pINN) for the generic name of JNJ-26854165. 1 ), a novel tryptamine compound with radiosensitizing activity in vitro and in tumor xenografts